BioOhio News Archive Winter 2009

December 4, 2009

Ohio bioscience is hiring: Inquire within

Despite a bumpy economy, many Ohio bioscience-related firms are bucking the prevailing trends by expanding their business and adding staff. Perhaps it’s because bioscience and healthcare are more recession-resilient than other industries. Perhaps it’s because hard-working and innovative Ohioans are leading these organizations. Whatever the reason, we thought we’d help some BioOhio members find the talent to fuel their growth. And please feel free to forward this to friends, family, or former colleagues around the world that might be interested in an Ohio bioscience-related career.

Meridian Bioscience


Current openings include: Vice President, R&D – Will have authority and responsibility for leadership of R&D, and have track record of leading design and development of diagnostic products brought to the market. Senior Scientist Molecular – Design, develop, and execute the R&D of molecular diagnostic projects and supervise research associates. Manage the transfer of molecular products. Visit for full descriptions or submit resume to

CTI Clinical Trial and Consulting Services


Current Openings: Clinical Research Associate; Clinical Study Manager; Clinical Safety/Regulatory Specialist. For more information, visit us at: Or e-mail your resume

MetaMol Theranostics


Current opening: Senior Scientist. MetaMol Theranostics is a biotech start-up company with an innovative anti-cancer technology. The company seeks to fill a Scientist position to evaluate therapeutic and diagnostic antibodies. Responsibilities include conducting cellular and molecular assays to evaluate the antibodies, testing of the most effective neutralizing antibodies in in vivo systems, and developing diagnostic kits for the detection of the target molecule. Send CV and references to



Alkermes develops medicines with the potential to change people’s lives for the better. Our goal is to bring forward safe and effective medicines that can make it easier for patients to consistently get the medication they need, day after day. Seeking qualified candidates in the following areas: Analytical Development, Process Development, and Facilities. For consideration, please visit our website at

Modular Genetics


Modular Genetics is a green chemistry company expanding in Ohio with the following positions available. Fermentation Scientist and Site Lead: Ph.D., 3+ yrs. industry experience. Separations Scientist: Ph.D., 3+ yrs. experience. Bioprocessing Foreman: B.S., 5+ yrs. experience. To learn more, go here,—Jobs.aspx, and then type Modular Genetics in the keyword search box.

Diagnostic HYBRIDS


Research Technician II/Research Associate: Requires MS (or BS/BA and 5 years experience) in biological sciences, BSL-2 experience. Responsibilities: nucleic acid purification; RT-PCR; purification, quantitation of PCR products; DNA ligations; yeast and bacterial plasmid DNA purifications, transformations; immunoassay, biological assays development, validation, implementation. Apply at

Ben Venue Laboratories

(Bedford, NE Ohio)

Formulation Chemist – 3rd shift. Formulation Supervisor – Open shift. Formulation Scientist – 1st shift. Microbiologist – 2nd shift. Applicants are required to have a 4-year degree in a scientific field. Visit to apply.


(Maineville, SW Ohio)

A personalized medicine company specializing in the field of pharmacogenetics has an immediate opening for a Lab Director to develop and direct our clinical molecular genetics laboratory. Experience with obtaining CLIA-certification and as a CLIA-certified laboratory director is preferred. Contact us at

Hicks Partners, LLC


Hicks Partners, LLC has an opening for an experienced Grant Writer and Coordinator. The individual selected will research and identify funding sources to support existing and future clients, and coordinate the development, writing, and submission of grant proposals. Hicks Partners provides grant services in the areas of Ohio Third Frontier, SBIR/STTR grants, Clean Ohio Fund, economic development grants, and other business incubating grants. For more info, please click here.



USB/Affymetrix Ohio provides biochemical and molecular biology products and offers its employees a dynamic work experience in the growing field of life science and biotechnology. More than a dozen Ohio-based jobs are posted on the Affymetrix career web page:, enter “Ohio” in keyword search box.



A leading developer and manufacturer of sterile specialty pharmaceutical products that continues to expand operations is currently looking for a Regulatory Affairs Manager to manage daily department activities including regulatory submissions, labeling and post-marketing activities. More information at Contact John Garrett at

NovelMed Therapeutics


Startup biotechnology company developing anti-inflammatory, anti-thrombotic, and anti-tumor therapies. Open positions include: Director of Business Development, to focus on developing business plan, managing finances, and obtaining partnerships with large pharmaceutical companies (MBA required); Research Scientist, to characterize antibody based therapeutics for the both acute and chronic clinical conditions (PhD and industry experience required). Contact or 216-916-7300, x101.

Wright Brothers, Inc.

(Cleveland-based opportunity)

Posting for Technical Sales Person. Description: Generate new business for independently-owned industrial gas company’snew satellite location. Qualifications: Technical/scientific experience, sales closer, self-motivated, fast-learner, non-nicotine user. Commission; full benefits. Email resume to ( or fax to 513-731-2223, attn: E.Brickey.

Rocket Ventures


Northwest Ohio’s premier venture capital organization has immediate openings for entrepreneurs with bioscience experience to work with start-up bioscience companies. Contact Greg Knudson at;



Market Research Analyst: This market research job will support all of BioOhio’s analytical efforts with special emphasis on supporting the goals of the BioOhio led, “Targeted Asset Based Company Attraction Project for Biosciences” or ABCAP. This person will become an expert on the key bioscience assets in Ohio, its important players and decision makers across the state. For more information, email or call 614/675-3686, x1262.
To find more Ohio bioscience-related jobs, check out BioOhio’s Careers & Jobs page (—Jobs.aspx), where you’ll find an Ohio-centric, categorized portal as well as a link to

Ohio bioscience and healthcare industry impact: $148 billion

A report published by BioOhio in January reveals the importance of bioscience and health care to Ohio’s economic recovery.
The overall economic impact of Ohio-based bioscience is $148.2 billion, representing 15.7% of Ohio’s total economic output. Bioscience also directly and indirectly generates 1.4 million jobs in Ohio.
BioOhio’s comprehensive definition of the bioscience industry includes three integrated sectors: commercial bioscience entities, hospitals and healthcare providers, and medical colleges. The commercial bioscience sector alone accounted for a $33.8 billion overall economic impact and 50,100 direct jobs in 2007, up from $27.3 billion and 48,485 direct jobs in 2006. When indirect and induced jobs are factored, the commercial bioscience employment impact jumps to 135,136.
Analysis of commercial bioscience industry segments revealed research and development as the top employment sector (12,415), while agricultural biotechnology contributed the largest direct economic impact ($10.7 billion) in 2007. Medical device and equipment manufacturers directly employed 9,757 Ohioans.
Bioscience, medical technology, and research organizations continue to thrive in Ohio. As of December 2008, 1,141 bioscience-related entities were operating in the state. While company launches and relocations explain some of the 39.5% increase since last year’s count (818), the expansion is mostly attributable to a more thorough census of organizations. For instance, 636 Ohio companies are FDA-certified to manufacture medical devices and 88 facilities in the state are FDA-certified to manufacture pharmaceuticals. BioOhio determined that nearly half of these companies are actively involved in the value chain of at least one commercial bioscience product.
Bioscience-related entities include those involved in research, development, and marketing of pharmaceuticals, diagnostics, bioinformatics, medical devices, medical equipment, biotechnology products, and health-related products.
Half of Ohio’s bioscience entities (574) are located in northeast Ohio, which includes the Cleveland area, Akron, Canton, and Youngstown. Southwest Ohio, anchored by Cincinnati, and central Ohio, which includes the capital Columbus, are each home to about 200 of the state’s bioscience-related entities.
“The Ohio Bioscience Growth Report clearly shows that Ohio continues to make great strides in the biosciences, and our bioscience industry is on the fast track creating jobs of the future for Ohioans,” said Lieutenant Governor Lee Fisher, who also serves as Director of the Ohio Department of Development. “We are once again rated as one of the nation’s top technological innovators, recognition of the wide diversity of world-class research institutions, medical centers, and visionary companies that call Ohio home.”
From 2004 to 2007, an average of 66 new companies began operation in Ohio each year. In 2007, Ohio welcomed 60 bioscience organizations by way of new company launches or companies establishing their first facility in the state, including AcelleRX Therapeutics (Cleveland), Akebia Therapeutics (Cincinnati), Freedom Meditech (Cleveland/Toledo), and Traycer Diagnostic Systems (Columbus).
From 2005 through 2007, 100 bioscience-related companies either expanded operations or announced new facilities in Ohio; 36 projects occurred in 2007. Noteworthy 2007 examples include: Philips Medical expanding R&D space for their imaging systems in Highland Heights; growing CROs like Charles River Labs in Spencerville and WIL Research in Ashland; Ben Venue Labs’ new 244,000 square foot facility; and Cardinal Health breaking ground on a $50 million, 250,000 square foot facility at its Dublin headquarters.
“The current global economic crisis is affecting every industry sector,” said BioOhio President & CEO Tony Dennis, “but a solid infrastructure and sustained growth will help Ohio’s bioscience industry weather the storm and position it for explosive growth when the economy recovers.”
Commenting on the strength of agricultural biotechnology in the state, Ohio State’s Vice President for Agricultural Administration Bobby Moser said, “Agbioscience is a key driver of economic progress and technology-based economic development for the U.S. and Ohio. Because of a strong R&D and outreach infrastructure together with the support of multiple stakeholders across the state, Ohio has moved into an early leadership position in this area.”
Funding for research, company formation, and company expansion also continued to rise in Ohio. Overall, nearly $2.5 billion were invested across Ohio to accelerate bioscience growth in 2007, almost doubling the 2006 total. The sources of funding include venture capital, angel funds, IPOs, SBIR/STTR, state biomedical grants, acquisitions, and NSF and NIH grants.

Let’s meet in Columbus

BioOhio Statehouse Day & Reception on April 7
To help BioOhio members build relationships with their state legislators, BioOhio is holding a legislative day and reception in the Atrium of the Statehouse on April 7. While the reception begins at 5:00pm, we encourage BioOhio members to come to Columbus between 2:00pm and 5:00pm to meet with your legislators.
As constituents, you have significant clout, being able to provide a local perspective and being relied on for re-election. The education you provide your elected officials will help them develop agendas and will be reflected in their decisions.
On behalf of BioOhio, Colby & Co. will assist BioOhio members who are interested in meeting with their legislators in the afternoon. The early evening reception will include light hors d’oeuvres and drinks. In appreciation of our members, there is no charge to attend.

Please contact Jen Goldsberry, or 614/675-3686, x1004 for more information or to RSVP.

Working on Workforce Development
DOL Bioscience Industry Competency Model
The US Department of Labor, Employment and Training Administration (DOL-ETA) has just begun Phase II review of a skills competency model to help shape educational and workforce training content for the bioscience industry.
BioOhio, as an active member of DOL-ETAs “Bioregions” network, participated in the Phase I review of the model. We solicited input from a number of Ohio bioscience companies—primarily manufacturers—and community colleges and career centers. BioOhio Sr. Director of Workforce Bill Tacon shared their recommendations with DOL-ETA for consideration in the Phase II model.
If you are interested in receiving a copy of the skills competency model, contact Bill Tacon at
Engaging Future Bioscience Workers
Last November, Tacon chaired a panel of three southwest Ohio bio-manufacturing industry experts sharing information and advice with some 150 Miami Valley Tech Prep high school students at Sinclair Community College.
Panelists were Amylin Ohio’s Brad Hughes, Eurand’s Peter Ercoli, and Mike Deperro from Alkermes. Each spoke specifically to their companies business, workforce needs and career opportunities. Tacon offered an overview of Ohio’s bioscience industry growth and career landscape, emphasizing the expansion in the manufacturing sector.
The event was organized by Dave McDaniel, the Miami Valley bioscience Tech Prep coordinator, who wants to open the students’ eyes to the exciting career opportunities available in biomanufacturing in their region. The students took full advantage of the Q&A session with the panelists and toured Sinclair’s biotechnology lab.
Career Fairs

BioOhio will turn one big career fair in the fall in Columbus into three regional career fairs in the spring: Cleveland, April 22; Cincinnati, week of May 11 (date TBD); Columbus, May 27. More details in coming weeks. For information on exhibiting, email

BioOhio Government Affairs Update
with contributions from Colby & Co.

New General Assembly

In early January, the 128th General Assembly was sworn in. The new Speaker for the Ohio House of Representatives, the Honorable Armond Budish (D-Beachwood), is interested in working with BioOhio on economic development and job growth in Ohio. BioOhio has a positive relationship with Speaker Budish’s office and looks forward to working together this session. In the Senate, President Bill Harris (R-Ashland) continues to provide strong leadership. We will be working with both House and Senate leaders to promote the bioscience industry in Ohio.
More than a third of the House of Representatives are serving for the first time, providing unique opportunities and challenges in furthering a bioscience agenda. In the coming weeks, BioOhio will be briefing each new legislator on issues that affect the industry and providing innovative ideas for job growth and workforce improvement. BioOhio also will host a Statehouse Reception for our members and state legislators on April 7. See “Let’s Meet in Columbus” article for more details.

Ohio Biennial Budget 2010-2011

A summary of relevant portions of the State’s proposed biennial budget.
Ohio Department of Development: ODOD commits to the renewal and improvement of the Ohio Third Frontier program, currently funded through 2012, with a continued focus on supporting commercialization. The budget provides funding to integrate Ohio’s technology-based economic development programs and align the Edison Centers and Incubators with ODOD’s targeted industries and the technological focus of the Ohio Third Frontier program.
Workforce: The budget will continue to provide support for the Board of Regents, the Department of Job and Family Services, and the Department of Development by funding workforce training and education to prepare Ohio’s citizens for the jobs of the future. The Ohio Skills Bank, Ohio Workforce Guarantee, and regionally based workforce directors will be financed to work collaboratively with industry and industry-facing organizations like BioOhio.
Co-op/Internship Program: The 127th General Assembly passed H.B. 554, legislation that has been enacted to invest $50 million annually for five years to retain Ohio’s graduates in the state by providing solid career opportunities and linking employers with qualified Ohio graduates.
Choose Ohio First Scholarships: Funding will continue to provide for a third round of awards totaling $50 million in scholarship support. This scholarship program aims to promote the STEMM fields (science, technology, engineering, mathematics, and medicine).
Research Scholars: $8 million is provided each fiscal year from the Third Frontier bond proceeds to support the Research Scholars program, which attracts senior research talent and promotes collaboration to build and sustain promising fields of research.

Ohio Jobs Stimulus Plan Update

Since the announcement of the $1.57 billion Ohio Bipartisan Jobs Stimulus Plan in April, we have kept Ohio’s bioscience community updated on the status of the plan’s $100 million biomedical component. Unfortunately the availability of the proposed $100 million remains unresolved. A judge ruled Tuesday that the issue needs to go to trial and that the money must remain untouched by either the State of Ohio or The American Legacy Foundation until resolved. We will continue to bring you updates as we get them. This Dispatch article provides additional details:

Ohio Chamber of Commerce

This year’s Ohio Chamber of Commerce advocacy agenda includes supporting “policies and activities that promote the growth and expansion of Ohio’s diverse bioscience industry.” The Chamber’s Vice President of Governmental Affairs Linda Woggon has asked BioOhio to collaborate and advise the Chamber on bioscience economic development issues. At a briefing organized by the Chamber on January 29, BioOhio President & CEO Tony Dennis provided an overview of Ohio’s bioscience industry to Rep. Jay Goyal and several other members of the House Majority leadership team.

Federal Initiatives

BioOhio has substantially increased the Ohio bioscience industry’s presence in D.C. over the past year and will continue to advocate the Ohio delegation for bioscience-related funding and fight for industry goals.
BioOhio President & CEO Tony Dennis, BioOhio Sr. Director of Workforce & Education Bill Tacon, and Rick Colby and Sarah Weigand from Colby & Company visited nine members of the Ohio delegation in early February.
“As Ohio gains national bioscience prominence and as our industry grows and becomes a larger part of Ohio’s economy, BioOhio will continue to address issues of common interest but also address areas that are of specific interest to Ohio,” said Dennis. “Ohio’s bioscience industry is very well positioned to benefit from the federal stimulus, which can help us maintain our growth momentum and ensure that bioscience is part of the long-term solution for creating a robust and resurgent Ohio economy.”
A follow up visit is planned in the near future to meet with the members that we were unable to see in February and to continue to push the BioOhio agenda, which includes industry-driven workforce development, promoting bioscience manufacturing, and health information technology collaborations.

Webinar opens eyes, ears to another source of research funding

Bioscience companies and academic researchers are increasingly turning to an alternative source of funding to advance their research: disease-focused nonprofit foundations.
A January 15 BioOhio webinar titled “Foundation Funding” focused on the emerging trend of disease-related foundations providing funding to start-up and emerging bioscience companies to pursue treatments and cures. Click here to view archived webinar.
BioOhio brought together three forward-thinking foundations that are leaders in the “venture philanthropy” movement, and an Ohio company that has received foundation funding. Research leaders from the Juvenile Diabetes Research Foundation, the Michael J. Fox Foundation, and the Prostate Cancer Foundation discussed their funding philosophies, programs, and focus areas.
Cleveland-based Copernicus Therapeutics President Bob Moen shared helpful advice from the funding recipient perspective. To date, Copernicus has received $6 million from the Cystic Fibrosis Foundation and $100,000 in direct support from the Michael J. Fox Foundation.
In addition to our panelists and the CF Foundation, several other foundations are also investing in for-profit companies to advance potential cures including, but not limited to: Myelin Repair Foundation; Gates Foundation; Multiple Myeloma Foundation; Leukemia & Lymphoma Society; Wellcome Trust; and the Muscular Dystrophy Association, among others.
The webinar panelists encouraged attendees to learn more about foundations involved in diseases that match up with their own company’s focus areas. While The Michael J. Fox Foundation targets Parkinson’s Disease (PD), Associate Director of Research Programs Sohini Chowdhury suggested that academic and industry researchers involved in other CNS diseases consider whether their work has applicability to PD in order to utilize the foundation’s resources.
Disease foundations invested $75 million in bioscience companies in 2007, a tenfold increase since 2000. The CF Foundation alone has awarded $300+ million to for-profit companies over the past decade.

Recommended reading: a December 2008 article on how the economy may affect foundation’s funding

Ohio Bioscience News Briefs

BIO 2009 Convention

In collaboration with the Ohio Department of Development (ODOD), the Ohio Business Development Coalition, and Team Ohio, BioOhio will coordinate Ohio’s presence at this year’s BIO International Convention in Atlanta, May 19-21. Underscoring bioscience’s prominent inclusion in ODOD’s Stategic Plan, Lt. Governor Lee Fisher will attend the convention for the second straight year.
The BIO International Convention is the largest global bioscience industry event. It attracts the biggest names in biotech, pharma, and medtech, offers key networking and partnering opportunities, and provides insights and inspiration on major trends affecting the industry. Nearly 20,000 attendees are expected at this year’s show.
This year, your company can become a focal point of Ohio’s presence at the BIO International Convention. We are seeking 4 booth partners—one for each corner of our 20’x20’ island booth—to promote their brands and share their messages.

New Member Roll-Call

A hearty welcome to new members that have joined the BioOhio family since mid-October 2008. And special recognition and thanks to OhioHealth Research & Innovation Institute, which upgraded to a Pillar Member.
    ADF Engineering, Inc. (
    Athens Area Chamber of Commerce (
    Beachwood Chamber of Commerce (
    Eisai, Inc. (
    Glucometrics, Inc.
    MetaMol Theranostics (
    Modular Genetics, Inc. (
    O’Keefe Electronics, Inc. (
    paul-lawrence associates (
    Southworth & Associates, LLC
    Stonefly Communications Group (
    Sumitomo Plastics America (
    Synerfac Technical Staffing (
    The Carmon Group (
    TT Electronics IMS, Inc. (
    US Endoscopy (
    WIL Research Laboratories (
    Dale Phillips
    Diane Fels
    Linda Law
    Melanie Jeffers
    Michael Arhin
    Mihaela Jekic
    Nicole Bauer
    Stephen Vetter

BioOhio is Ohio’s only statewide bioscience membership and development organization. To learn more about membership, check this out or call 614/675-3686, x1004.

OVALS Conference and other upcoming bioscience events in Ohio

The Ohio Valley Affiliates for Life Sciences (OVALS) will hold their 7th Annual Conference on April 2-3 in Dayton. The conference will focus on the major diseases driving biotechnology advances, game-changing scientific advances,types of technology that will impact our healthcare in the future, and funding priorities expected to emerge under the new political administration. OVALS is a collaborative effort of the University of Cincinnati, Ohio University, Wright State University, University of Louisville, University of Kentucky, Air Force Research Laboratory, BioOhio, Bluegrass Business Development Partnership, CincyTechUSA, Edison Biotechnology Institute, and Indiana Health Industry Forum. For more information or to register:

Getting Your Brand/Product/Service/Name “Out There”: A Marketing Communications Primer for Bioscience Companies on March 3 at JumpStart in downtown Cleveland.With members Stonefly Communications, Corky Thacker Communications, OffWhite Salter and Giraffe, Inc., BioOhio presents a workshop to discuss branding, marketing communications goal and strategy development, and tools and tactics that will deliver results.A wine and cheese networking reception will follow. Please RSVP by sending full contact information to Jen at, or (614) 675-3686, x1004. Workshop is FREE for BioOhio members, $10 for non-members. For more details on these and other Ohio bioscience events: